Department of Orthopaedics & Traumatology, Stem Cells and Regenerative Medicine Laboratory, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, China.
Orthopaedic Center, Affiliated Hospital of Guangdong Medical University, Guangdong Medical University, Zhanjiang, China.
Cytotherapy. 2021 Jul;23(7):590-598. doi: 10.1016/j.jcyt.2020.12.005. Epub 2021 Feb 3.
BACKGROUND AIMS: Distraction osteogenesis (DO) is a surgical technique to promote bone regeneration that requires a long time for bone healing. Bone marrow-derived mesenchymal stromal cells (MSCs) have been applied to accelerate bone formation in DO. Allogeneic MSCs are attractive, as they could be ready to use in clinics. Whether allogeneic MSCs would have an effect similar to autologous MSCs with regard to promoting bone formation in DO is still unknown. This study compares the effect of autologous MSCs versus allogeneic MSCs on bone formation in a rat DO model. METHODS: Rat bone marrow-derived MSCs were isolated, characterized and expanded in vitro. Adult rats were subjected to right tibia transverse osteotomy. On the third day of distraction, each rat received one injection of phosphate-buffered saline (PBS), autologous MSCs or allogeneic MSCs at the distraction site. Tibiae were harvested after 28 days of consolidation for micro-computed tomography examination, mechanical test and histological analysis. RESULTS: Results showed that treatment with both allogeneic and autologous MSCs promoted bone formation, with significantly higher bone mass, mechanical properties and mineral apposition rate as well as expression of angiogenic and bone formation markers at the regeneration sites compared with the PBS-treated group. No statistical difference in bone formation was found between the allogeneic and autologous MSC treatment groups. CONCLUSIONS: This study indicates that allogeneic and autologous MSCs have a similar effect on promoting bone consolidation in DO. MSCs from an allogeneic source could be used off-the-shelf with DO to achieve early bone healing.
背景目的:牵张成骨术(DO)是一种促进骨再生的外科技术,需要很长时间才能使骨愈合。骨髓间充质基质细胞(MSCs)已被应用于加速 DO 中的骨形成。同种异体 MSCs 具有吸引力,因为它们可以在临床上随时使用。同种异体 MSCs 是否会在促进 DO 中的骨形成方面产生与自体 MSCs 相似的效果尚不清楚。本研究比较了自体 MSCs 与同种异体 MSCs 对大鼠 DO 模型中骨形成的影响。
方法:分离、鉴定和体外扩增大鼠骨髓源性 MSCs。成年大鼠行右侧胫骨横行截骨术。在牵张的第三天,每只大鼠在牵张部位注射磷酸缓冲盐水(PBS)、自体 MSCs 或同种异体 MSCs。在整合 28 天后收获胫骨,进行微计算机断层扫描检查、力学试验和组织学分析。
结果:结果表明,与 PBS 治疗组相比,同种异体和自体 MSCs 治疗均可促进骨形成,再生部位的骨量、力学性能和矿化沉积率以及血管生成和骨形成标志物的表达明显更高。同种异体和自体 MSC 治疗组之间的骨形成无统计学差异。
结论:本研究表明,同种异体和自体 MSCs 对促进 DO 中的骨整合具有相似的作用。来自同种异体来源的 MSCs 可与 DO 一起即取即用,以实现早期骨愈合。
Stem Cell Res Ther. 2016-9-10
J Oral Maxillofac Surg. 2012-7
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2018-5-15
Hua Xi Kou Qiang Yi Xue Za Zhi. 2016-4
Front Med (Lausanne). 2024-2-23
Signal Transduct Target Ther. 2023-5-17
Bioengineering (Basel). 2022-10-5
Front Bioeng Biotechnol. 2022-1-18